Intimation under Regulation 30 for Allotment of Fully Convertible Warrants

Date: November 04, 2026 Department of Corporate Services, BSE Ltd., Ground Floor, P.J Towers, Dalal Street, Fort, Mumbai – 400 001 Dear Sir(s), BSE Scrip Code: 512063 – Wardwizard Healthcare Limited Sub: Allotment of 1,08,70,000 Warrants convertible into Equity Shares of the Company to the Promoter and Non-Promoter allottees. Ref: Intimation as per Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Pursuant to the Regulation 30 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,as amended, read with relevant circulars thereto issued by Securities and Exchange Board of India from time to time (“SEBI LODR Regulations”) and in compliance with the Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI ICDR Regulations”) and approval accorded by the Shareholders of Wardwizard Healthcare Limited (“the Company”) at their 42nd Annual General Meeting held on 30th September, 2026, and In-Principle approval granted by the BSE Limited on 22nd October, 2026, and upon receipt of Rs. 2,71,75,000/- (Rupees Two Crore Seventy-One Lakh Seventy-Five Thousand Only) i.e. the 25% of the total amount payable towards subscription of the warrants from all the allottees, we wish to inform that the Board of Directors of the Company vide their Resolution passed through Circulation* today i.e. Wednesday, 4th November, 2026, has considered and approved the allotment of 1,08,70,000 Warrants convertible into equivalent number of Equity Shares of the Company having face value of Rs. 10/- per Equity Share within a period of 18 months from the date of allotment i.e 4th November, 2026, at an Issue Price of Rs. 10/- (Rupees Ten Only) to the following Promoter and Non-Promoter allottees: Sr Name of the Proposed Category No. of Subscription Amount No Allottees Convertible Amount (25%) Received Warrants (25%) proposed to be (₹ in INR) allotted (₹ in INR) 1. Yatin Sanjay Gupte Promoter/Promoter 4200000 2.5 1,05,00,000 Group 2. Sheetal Mandar Promoter/Promoter 1800000 2.5 45,00,000 Bhalerao Group 3. Ram Chander Sharma Non-Promoter Group 2,00,000 2.5 5,00,000 4. Nitu Sharma Non-Promoter Group 2,00,000 2.5 5,00,000 5. Ram Chander Sharma Non-Promoter Group 2,00,000 2.5 5,00,000 6. Shyam Sunder Sharma Non-Promoter Group 2,00,000 2.5 5,00,000 7. Hemlata Sharma Non-Promoter Group 2,00,000 2.5 5,00,000 8. Shyam Sunder Sharma Non-Promoter Group 2,00,000 2.5 5,00,000 9. Aakanksha Kabra Non-Promoter Group 2,50,000 2.5 6,25,000 10. Sanjay Kumar Sharma Non-Promoter Group 3,00,000 2.5 7,50,000 11. Pooja Chotia Non-Promoter Group 3,00,000 2.5 7,50,000 12. Havish Suppliers LLP Non-Promoter Group 3,00,000 2.5 7,50,000 13. Kailash Dhanuka HUF Non-Promoter Group 3,30,000 2.5 8,25,000 14. Ruchika Dhanuka Non-Promoter Group 3,00,000 2.5 7,50,000 15. Arpit Kabra Non-Promoter Group 6,30,000 2.5 15,75,000 16. P. B. Films Limited Non-Promoter Group 6,30,000 2.5 15,75,000 17. Kayan Investment & Non-Promoter Group 6,30,000 2.5 15,75,000 Trading Company Private Limited 1,08,70,000 2,71,75,000 Total This is further to inform that the Company has received a written communication from Mr. Ilyashbhai Dhobi, expressing his inability to participate in the proposed issue of Fully Convertible Warrants. Further, Mr. Yatin Sanjay Gupte has intimated the Company of his decision to subscribe to 42,00,000 Fully Convertible Warrants instead of the originally proposed 52,00,000 warrants. Accordingly, the total number of Fully Convertible Warrants proposed to be allotted pursuant to the issue shall stand reduced from 1,25,00,000 to 1,08,70,000 warrants. Further, the aforesaid warrant(s) are being allotted in electronic form and are subject to lock-in, in compliance with the applicable provisions of SEBI ICDR Regulations. The conversion of warrants into equivalent number of equity shares of the Company can be exercised by the warrant holder(s) at any time during the period of eighteen months from the date of allotment of Warrants i.e. 4th November, 2026, in one or more tranches, upon payment of the remaining 75% of the amount payable against each such warrant before the last date of conversion of warrants. Since the Company has allotted warrants, presently there is no change in the paid-up equity share capital of the Company. The details as required for issuance of securities on preferential basis under SEBI LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 with respect to issuance of securities is enclosed as Annexure - A to this letter. This is for your information and records please. [*Note: The last approval by way of circular resolution was received at 06:02 P.M (IST) on Wednesday, 4th November, 2026]. Thanking You, Yours faithfully, For Wardwizard Healthcare Limited Rajbala Kiroriwal Company Secretary & Compliance Officer Membership No. A51986 Enclosed: As above Annexure-A The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as under: Particulars Details Type of securities allotted Convertible Warrants Type of Issuance Preferential Allotment Total number of securities proposed to be 1,08,70,000 warrants convertible into issued or total amount for which the securities equivalent number of Equity shares of the will be issued company. Number of Investors 17 Name of Investors Annexure-A1 Post allotment of securities – outcome of the The details of the shareholding of the allottees subscription, issue price/ allotted price (in case in the Company prior to and after the of convertibles), number of investors Preferential allotment has been mentioned in the Annexure – 1A. The Issue Price of the warrants is Rs. 10/- per warrant determined as per the applicable provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The number of investors are 17 (Seventeen). In case of convertibles – intimation on Each Warrant is convertible into One (1) conversion of securities or on lapse of the tenure equity share of Rs. 10 each issued at par of the instrument based on the Valuation Report obtained from Independent Registered Valuer and the conversion can be exercised at any time within a period of 18 months from the date of allotment i.e 4th November, 2026, in one or more tranches, as the case may be and on such other terms and conditions as applicable. The remaining 75% of the consideration shall be payable on the exercise of options against each such warrant. The Warrants proposed to be issued shall be subject to appropriate adjustment, if during the interim period, the Company makes any issue of equity shares by way of capitalization of profits or reserves, demerger/ realignment, rights issue or undertakes consolidation/ sub- division/ reclassification of equity shares or such other similar events or circumstances requiring adjustments. Issue price per warrant Rs. 10/- each (Issue of warrants at par based on the valuation report obtained from Independent Registered Valuer) Total amount raised Rs. 10,87,00,000/- (Rupees Ten Crore Eighty-Seven Lakhs Only) Conversion ratio Each of the Warrants is exercisable into 1 (One) Equity Share having face value of Rs. 10/- (Rupees Ten only) each. Upfront payment received Rs. 2,71,75,000/- (Rupees Two Crore Seventy-One Lakh Seventy-Five Thousand Only) (25% of total consideration) Balance amount payable on conversion Rs. 8,15,25,000/- (Rupees Eight Crore Fifteen Lakh Twenty-Five Thousand Only) (75% of total consideration) Category of allottee(s) Promoter and Non-Promoter Time period for conversion On or before 18 months from the date of allotment. Date of allotment 04/11/2026 Lock-in period The Warrants allotted shall be locked-in in compliance with the appl [Showing first 8,000 characters — download PDF for full document]